159 related articles for article (PubMed ID: 35583846)
21. The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization.
Xie P; Chao Q; Mao J; Liu Y; Fang J; Xie J; Zhen J; Ding Y; Fu B; Ke Y; Huang D
J Cell Mol Med; 2021 Dec; 25(23):10980-10989. PubMed ID: 34773364
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide reduces USP13 stability through c-Jun N-terminal kinase activation in Kupffer cells.
Yu F; Li Y; Ye Q; Miao J; Taleb SJ; Zhao Y; Zhao J
J Cell Physiol; 2021 Jun; 236(6):4360-4368. PubMed ID: 33169399
[TBL] [Abstract][Full Text] [Related]
23. USP13 interacts with cohesin and regulates its ubiquitination in human cells.
He X; Kim JS; Diaz-Martinez LA; Han C; Lane WS; Budnik B; Waldman T
J Biol Chem; 2021; 296():100194. PubMed ID: 33334891
[TBL] [Abstract][Full Text] [Related]
24. HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
Song H; Chen X; Jiao Q; Qiu Z; Shen C; Zhang G; Sun Z; Zhang H; Luo QY
Thyroid; 2021 Feb; 31(2):233-246. PubMed ID: 32772829
[No Abstract] [Full Text] [Related]
25. Germline Mutations in Familial Papillary Thyroid Cancer.
Sarquis M; Moraes DC; Bastos-Rodrigues L; Azevedo PG; Ramos AV; Reis FV; Dande PV; Paim I; Friedman E; De Marco L
Endocr Pathol; 2020 Mar; 31(1):14-20. PubMed ID: 32034658
[TBL] [Abstract][Full Text] [Related]
26. HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.
Pinheiro M; Drigo SA; Tonhosolo R; Andrade SCS; Marchi FA; Jurisica I; Kowalski LP; Achatz MI; Rogatto SR
Oncotarget; 2017 Jun; 8(25):40896-40905. PubMed ID: 28402931
[TBL] [Abstract][Full Text] [Related]
27. Amplification of USP13 drives ovarian cancer metabolism.
Han C; Yang L; Choi HH; Baddour J; Achreja A; Liu Y; Li Y; Li J; Wan G; Huang C; Ji G; Zhang X; Nagrath D; Lu X
Nat Commun; 2016 Nov; 7():13525. PubMed ID: 27892457
[TBL] [Abstract][Full Text] [Related]
28. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
29. USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer.
Xie H; Zhou J; Liu X; Xu Y; Hepperla AJ; Simon JM; Wang T; Yao H; Liao C; Baldwin AS; Gong K; Zhang Q
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2119854119. PubMed ID: 36037364
[TBL] [Abstract][Full Text] [Related]
30. USP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domains.
Scortegagna M; Subtil T; Qi J; Kim H; Zhao W; Gu W; Kluger H; Ronai ZA
J Biol Chem; 2011 Aug; 286(31):27333-41. PubMed ID: 21659512
[TBL] [Abstract][Full Text] [Related]
31. USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model.
Kwon J; Choi H; Ware AD; Morillo BC; Wang H; Bouker KB; Lu X; Waldman T; Han C
Oncogene; 2022 Mar; 41(13):1974-1985. PubMed ID: 35173307
[TBL] [Abstract][Full Text] [Related]
32. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
34. Src inhibitors in suppression of papillary thyroid carcinoma growth.
Henderson YC; Toro-Serra R; Chen Y; Ryu J; Frederick MJ; Zhou G; Gallick GE; Lai SY; Clayman GL
Head Neck; 2014 Mar; 36(3):375-84. PubMed ID: 23729178
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Activating Mutations of the
Borrelli N; Panebianco F; Condello V; Barletta JA; Kaya C; Yip L; Nikiforova MN; Nikiforov YE
Thyroid; 2019 Sep; 29(9):1279-1285. PubMed ID: 31407636
[No Abstract] [Full Text] [Related]
36. Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m
Wang C; Meng Y; Zhao J; Ma J; Zhao Y; Gao R; Liu W; Zhou X
Int J Biol Sci; 2023; 19(7):2289-2303. PubMed ID: 37151889
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of ubiquitin-specific protease 13-mediated degradation of Raf1 kinase by Spautin-1 has opposing effects in naïve and primed pluripotent stem cells.
Wang X; Wang X; Zhang X; Zhang Y; Zhu Z; Li Y; Zhang M; Ji J; Yu Y; Ye SD
J Biol Chem; 2021 Nov; 297(5):101332. PubMed ID: 34688658
[TBL] [Abstract][Full Text] [Related]
38. The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.
Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
[TBL] [Abstract][Full Text] [Related]
39. New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.
Costa V; Esposito R; Ziviello C; Sepe R; Bim LV; Cacciola NA; Decaussin-Petrucci M; Pallante P; Fusco A; Ciccodicola A
Oncotarget; 2015 May; 6(13):11242-51. PubMed ID: 25803323
[TBL] [Abstract][Full Text] [Related]
40. HABP2 G534E Variant in Papillary Thyroid Carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; He H; Senter L; de la Chapelle A
PLoS One; 2016; 11(1):e0146315. PubMed ID: 26745718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
